Matching articles for "iv drugs"
Issue 1278 · January 28, 2008
Doripenem (Doribax) - A New Parenteral Carbapenem

Doripenem ( Doribax - Ortho-McNeil Janssen), an intravenous (IV) carbapenem antibiotic with a spectrum of activity similar to that of imipenem and meropenem, has been approved by the FDA for treatment of…

Med Lett Drugs Ther. 2008 Jan 28; 50(1278):5-7
Doripenem ( Doribax - Ortho-McNeil Janssen), an intravenous (IV) carbapenem antibiotic with a spectrum of activity similar to that of imipenem and meropenem, has been approved by the FDA for treatment of complicated intra-abdominal and urinary tract infections. Use of doripenem for treatment of nosocomial pneumonia, including ventilator-associated pneumonia, is still under FDA review.
Issue 1276 · December 17, 2007 Free
Correction: Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures

On page 100 of the article " Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures ", under the section Highest-Risk Procedures, the word "rubber" should have been omitted. Placement of…

Med Lett Drugs Ther. 2007 Dec 17; 49(1276):104
On page 100 of the article " Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures ", under the section Highest-Risk Procedures, the word "rubber" should have been omitted. Placement of orthodontic rubber bands is not a highest-risk procedure that justifies prophylaxis; placement of orthodontic (metal) bands is. An orthodontic band is a metal ring that surrounds the tooth and is pressed into place causing movement in closely-spaced teeth and sometimes bleeding when the bands are placed close to the gumline.
Issue 1275 · December 3, 2007
Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures

The American Heart Association has issued its revised guidelines for prevention of infective endocarditis. Antimicrobial prophylaxis for dental procedures is now recommended only for patients at the highest…

Med Lett Drugs Ther. 2007 Dec 3; 49(1275):99-100
The American Heart Association has issued its revised guidelines for prevention of infective endocarditis. Antimicrobial prophylaxis for dental procedures is now recommended only for patients at the highest risk of severe consequences from endocarditis who are undergoing the highest-risk procedures. Endocarditis prophylaxis is no longer recommended for gastrointestinal (GI) and genitourinary (GU) procedures. When these changes are implemented, the number of patients receiving antimicrobial prophylaxis to prevent endocarditis should decline sharply.
Issue 1273 · November 5, 2007
A Once-Yearly IV Bisphosphonate for Osteoporosis

Zoledronic acid ( Reclast - Novartis) is the first bisphosphonate approved by the FDA for once-yearly intravenous (IV) treatment of osteoporosis in postmenopausal women. Reclast is also approved for treatment…

Med Lett Drugs Ther. 2007 Nov 5; 49(1273):89-90
Zoledronic acid ( Reclast - Novartis) is the first bisphosphonate approved by the FDA for once-yearly intravenous (IV) treatment of osteoporosis in postmenopausal women. Reclast is also approved for treatment of Paget's disease. Another IV formulation of zoledronic acid (Zometa) is approved for treatment of hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors.